hC Bioscience Funding: $40M Raised, Series A (2022)

hC Bioscience is based in Cambridge, Massachusetts. It has raised $40M in total funding. Latest round: Series A.

hC Bioscience funding overview

hC Bioscience is based in Cambridge, Massachusetts. hC Bioscience has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2022. The round record for hC Bioscience runs through 2022; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Takeda Ventures, 8VC, Taiho Ventures, Panacea Venture. 5 distinct backers are named across the disclosed rounds.

hC Bioscience at a glance

Total raised
$40M
Latest round
Series A
Latest round date
November 2022
Headquarters
Cambridge, Massachusetts
Notable investors
ARCH Venture Partners, Takeda Ventures, 8VC, Taiho Ventures, Panacea Venture

Frequently asked about hC Bioscience funding

How much has hC Bioscience raised?
hC Bioscience has raised $40M in total disclosed funding across the rounds on record.
Who has invested in hC Bioscience?
ARCH Venture Partners, Takeda Ventures, 8VC, Taiho Ventures, Panacea Venture are named among the investors backing hC Bioscience.
What was the latest hC Bioscience funding round?
The most recent disclosed round is a Series A, announced in November 2022.
Where is hC Bioscience based?
hC Bioscience is based in Cambridge, Massachusetts.
When did hC Bioscience last raise?
The last disclosed hC Bioscience round closed in November 2022 at Series A.

Round data for hC Bioscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Companies related to hC Bioscience (35)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026